Becker's Healthcare October 24, 2024
Alexandra Murphy

Independent pharmacies are fighting to stay profitable as pharmacy benefit managers favor big chains, KFF Health News reported Oct. 24.

Here are four things to know:

  1. PBMs, the middlemen managing most U.S prescriptions, have faced scrutiny for allegedly inflating drug prices and reducing reimbursements for smaller pharmacies.
  2. This year, some Georgia pharmacists hoped state lawmakers would pass legislation that would level the playing field by increasing reimbursements for independent pharmacies. However, Gov. Brian Kemp vetoed the bill, citing a projected...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Pharma, Pharma / Biotech
Related Articles:
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article